Diabetes Distress Clinical Trial
— CEDDOfficial title:
Coaching and Education for Diabetes Distress: a Randomized Controlled Trial (CEDD Trial)
| Verified date | January 2021 |
| Source | Baylor College of Medicine |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
Diabetes distress (DD) is a negative emotional reaction to a diagnosis of diabetes and concerns about the burden of managing diabetes, the risk of complications, and inadequate support system. DD is common among people with diabetes and is strongly associated with poor diabetes self-care and poor diabetes control. Reducing DD should thus be an important component of diabetes management. In line with the growing evidence, the American Diabetes Association now recommends that providers "routinely monitor people with diabetes for diabetes distress, particularly when treatment targets are not met". Despite increased recognition of the need to manage DD, interventions that are both feasible and effective for reducing DD in routine care settings are not yet known. A pilot study showed that health coaching (HC) has some efficacy in addressing DD but no adequately powered study has implemented a pragmatic research design capable of assessing the real-world effectiveness of HC in reducing DD. This study seeks to assess whether HC effectively reduces DD among primary care patients with diabetes, and whether HC is more effective than an educational program targeting DD. The investigators hypothesize that over a 6-month period, patients with poorly controlled diabetes and DD who enroll in and complete at least five HC sessions will achieve higher and clinically significant reductions in DD and HbA1c, and greater compliance with diabetes self-care recommendations than those who receive only an educational program targeting DD as part of usual diabetes care. The two-arm randomized controlled trial for patients with poorly-controlled diabetes is taking place at an academic family medicine practice in Houston, Texas. Both arms will receive usual care, which includes education about DD. In addition, the intervention arm will receive eight HC sessions over a five-month period. The primary outcome measure is reduction in DD over a six month period. Additional outcome measures include changes in glycemic control (HbA1C) and self-care practices (medication adherence, dietary, and physical activity behaviors). The study will also measure satisfaction and willingness-to-pay for HC to determine the extent to which HC, if effective for reducing DD, can be operationalized in similar healthcare settings.
| Status | Terminated |
| Enrollment | 19 |
| Est. completion date | September 17, 2020 |
| Est. primary completion date | February 25, 2020 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years to 75 Years |
| Eligibility | Inclusion Criteria: - Has had a diagnosis of type 2 diabetes for at least 6 months - Aged 18 to 75 years - Most recent HbA1c taken within 30 days was = 8.0 - At least moderate diabetes distress (a mean score = 2.0 on the 17-item Diabetes Distress Scale). Exclusion Criteria: - Moderately-severe to severe depression: Patient Health Questionnaire (PHQ9) score =15 - Other severe mental health disorder (e.g. Alzheimer's, schizophrenia) - Current pregnancy - Severe diabetes complications or functional deficits (e.g. kidney failure requiring dialysis, amputation, blindness). |
| Country | Name | City | State |
|---|---|---|---|
| United States | Baylor Family Medicine | Houston | Texas |
| Lead Sponsor | Collaborator |
|---|---|
| Baylor College of Medicine |
United States,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Diabetes distress score | Change in diabetes distress score as measured by the diabetes distress scale (DDS). DDS scores range from 1 to 6, with scores that are less than 2.0 being indicative of little or no distress. Hence scores of 2.0 and above are significant and higher values are indicative of worse outcome. | 3 months and 6 months from baseline | |
| Secondary | HbA1c | Change in glycemic control as measured by HbA1c | 3 months and 6 months from baseline | |
| Secondary | Self-care behaviors (medication adherence, dietary practices, and physical activity behaviors) | Change in medication adherence, dietary practices, and physical activity behaviors, as measured by the respective medication, diet, and exercise subscales of the Summary of Diabetes Self-Care Activities (SDSCA) questionnaire. | 3 months and 6 months from baseline |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04016558 -
Behavioral Approaches to Reducing Diabetes Distress and Improving Glycemic Control
|
N/A | |
| Recruiting |
NCT05584085 -
ACT-DE for Diabetes Distress and HbA1c in Adults With Type 2 Diabetes
|
N/A | |
| Completed |
NCT05563987 -
ACT-DE for Diabetes Distress in Adults With Type 2 Diabetes: A Pilot RCT
|
N/A | |
| Not yet recruiting |
NCT06398093 -
Developing and Testing a Self-Compassion Tool Kit to Improve the Care of Individuals With Type 2 Diabetes
|
N/A | |
| Completed |
NCT05517772 -
Expectations of People With Type 1 Diabetes About Voice-based Interventions to Support Diabetes Distress Management
|
||
| Recruiting |
NCT06436456 -
Use of an Online Intervention for the Treatment of Diabetes Distress in Patients With Type 1-Diabetes
|
N/A | |
| Not yet recruiting |
NCT06448338 -
UK MyREMEDY Clinical Trial
|
N/A | |
| Recruiting |
NCT05571306 -
Can Diabetes Distress be Reduced by Improving Entry to Care for Type 2 Diabetes Patients
|
N/A | |
| Recruiting |
NCT06320756 -
Examining the Feasibility of Wysa in Hindi
|
N/A | |
| Active, not recruiting |
NCT04587336 -
Tailored Approaches to Reduce Distress and Improve Self-Management for Veterans With Diabetes
|
||
| Completed |
NCT05140551 -
Emotional Wellbeing in Diabetes
|
N/A | |
| Recruiting |
NCT06308549 -
MyDiaMate For Remission Of Diabetes Distress In Type 1 Diabetes (MyREMEDY)
|
N/A |